Prospect

Today on TAP: The Trumpian right discovered antisemitism only when it needed a cudgel to bash the Ivies.

Its brutal war on Gaza is turning it into a pariah state and risking regional war.

Joe Biden has been an excellent president, but is also, I fear, the candidate least able to defeat Donald Trump. Other Democrats need to enter the race.

Gov. Glenn Youngkin wants to build next-generation nuclear plants and data centers. But he won’t tell Virginia residents what he’s doing.

Today on TAP: One more face of the creeping commercialism of higher education

The administration says it has the ability to employ march-in rights to lower drug prices. When will it actually use them?

New research shows widening gaps between red and blue states in life expectancy.

Our writing fellow pines for times when the video game industry wasn’t so consolidated and littered with junk fees galore.

TCGplayer, a subsidiary of eBay, has stalled negotiations on a first contract, despite the union winning an election in March.

Today on TAP: Mass bombing didn’t destroy the Vietnamese Communists and won’t destroy Hamas, but it sure kills lots of civilians.

Another African American dies in Mobile, as police shootings multiply in Alabama.

New York’s success in linking climate goals, industrial policy, and good-paying union jobs is the emblem of a long-sought political and policy alliance.

CFTC Chair Rostin Behnam’s term doesn’t end until 2026, but there are rumblings of an early exit to the private sector. Place your bets where he’ll end up next!

Advocacy groups offer a road map for how agencies can use existing authority to ban contracts that force workers to pay employers if they leave their job.

The clinical diagnosis of schizophrenia has been applied disproportionately to Black men, an artifact of a changing culture.

Today on TAP: Yesterday’s oral arguments in the ‘Moore’ case suggest some sympathy for a doctrine that could cost the government hundreds of billions in revenue.

The case for GDP plus GDD

Today on TAP: Opining against morality in foreign policy in 1989, he did nothing to diminish his blood-drenched image.

The supposed foreign policy “realist” was anything but.

And other fake news from the Supreme Court’s Purdue Pharma hearing